Annual Accounts Payable
$4.58 M
-$2.20 M-32.42%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual accounts payable is $4.58 million, with the most recent change of -$2.20 million (-32.42%) on December 31, 2023.
- During the last 3 years, PRLD annual accounts payable has risen by +$660.00 thousand (+16.84%).
- PRLD annual accounts payable is now -41.58% below its all-time high of $7.84 million, reached on December 31, 2021.
Performance
PRLD Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$5.92 M
-$249.00 K-4.04%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly accounts payable is $5.92 million, with the most recent change of -$249.00 thousand (-4.04%) on September 30, 2024.
- Over the past year, PRLD quarterly accounts payable has increased by +$613.00 thousand (+11.55%).
- PRLD quarterly accounts payable is now -46.47% below its all-time high of $11.06 million, reached on September 30, 2021.
Performance
PRLD Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PRLD Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.4% | +11.6% |
| 3 y3 years | +16.8% | -12.6% |
| 5 y5 years | +236.3% | -12.6% |
PRLD Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.6% | at low | -42.2% | +29.3% |
| 5 y | 5-year | -41.6% | +132.0% | -46.5% | +199.9% |
| alltime | all time | -41.6% | +236.3% | -46.5% | +199.9% |
Prelude Therapeutics Incorporated Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.92 M(-4.0%) |
| Jun 2024 | - | $6.17 M(+16.2%) |
| Mar 2024 | - | $5.31 M(+15.9%) |
| Dec 2023 | $4.58 M(-32.4%) | $4.58 M(-11.4%) |
| Sep 2023 | - | $5.17 M(-7.4%) |
| Jun 2023 | - | $5.58 M(-21.1%) |
| Mar 2023 | - | $7.08 M(+4.5%) |
| Dec 2022 | $6.78 M | $6.78 M(-33.9%) |
| Sep 2022 | - | $10.25 M(+63.4%) |
| Jun 2022 | - | $6.27 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.39 M(-5.7%) |
| Dec 2021 | $7.84 M(+100.0%) | $7.84 M(-29.1%) |
| Sep 2021 | - | $11.06 M(+61.6%) |
| Jun 2021 | - | $6.84 M(+41.3%) |
| Mar 2021 | - | $4.84 M(+23.5%) |
| Dec 2020 | $3.92 M(+98.6%) | $3.92 M(-22.7%) |
| Sep 2020 | - | $5.07 M(+46.2%) |
| Jun 2020 | - | $3.47 M(+75.8%) |
| Dec 2019 | $1.97 M(+44.9%) | $1.97 M |
| Dec 2018 | $1.36 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual accounts payable?
- What is the all time high annual accounts payable for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual accounts payable year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly accounts payable?
- What is the all time high quarterly accounts payable for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly accounts payable year-on-year change?
What is Prelude Therapeutics Incorporated annual accounts payable?
The current annual accounts payable of PRLD is $4.58 M
What is the all time high annual accounts payable for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual accounts payable is $7.84 M
What is Prelude Therapeutics Incorporated annual accounts payable year-on-year change?
Over the past year, PRLD annual accounts payable has changed by -$2.20 M (-32.42%)
What is Prelude Therapeutics Incorporated quarterly accounts payable?
The current quarterly accounts payable of PRLD is $5.92 M
What is the all time high quarterly accounts payable for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly accounts payable is $11.06 M
What is Prelude Therapeutics Incorporated quarterly accounts payable year-on-year change?
Over the past year, PRLD quarterly accounts payable has changed by +$613.00 K (+11.55%)